POC血液凝固検査の世界市場2019-2023

【英語タイトル】Global POC Coagulation Testing Market 2019-2023

Technavioが出版した調査資料(IRTNTR31829)・商品コード:IRTNTR31829
・発行会社(調査会社):Technavio
・発行日:2019年8月10日
・ページ数:124
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:アジア太平洋、ヨーロッパ、北米、その他
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社の本調査レポートでは、POC血液凝固検査の世界市場について調べ、POC血液凝固検査の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、POC血液凝固検査の市場規模をセグメンテーション別(エンドユーザー別(病院・診療所、ホームケア)、)と地域別(アジア太平洋、ヨーロッパ、北米、その他)に分けて算出しました。Technavio社はPOC血液凝固検査の世界市場規模が2019-2023期間中に年平均6%成長すると予測しています。
・サマリー
・レポートの範囲
・POC血液凝固検査の市場状況
・POC血液凝固検査の市場規模
・POC血液凝固検査の市場予測
・POC血液凝固検査の世界環境:ファイブフォース分析
・市場セグメンテーション:エンドユーザー別(病院・診療所、ホームケア)
・POC血液凝固検査の顧客状況
・主要地域別市場規模:アジア太平洋、ヨーロッパ、北米、その他
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global POC Coagulation Testing Market: About this market

POC coagulation testing involves the use of portable and handheld coagulation testing devices that offer healthcare professionals and patients reliable and quick coagulation monitoring capabilities irrespective of their location. Technavio’s POC coagulation testing market analysis considers sales from both homecare and hospitals and clinics. Our analysis also considers the sales of POC coagulation testing in Asia, Europe, North America, and ROW. In 2018, the hospitals and clinics segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the use of POC coagulation testing analyzers during perioperative procedures will play a significant role in the hospitals and clinics segment to maintain its market position. Also, our global POC coagulation testing market report looks at factors such as the growing adoption of POC testing devices, significant consumption of anticoagulant drugs, and rising demand for coagulation monitoring in preoperative and postoperative screening. However, high cost of POC analyzers and reagents in coagulation testing, stringent government regulation on POC coagulation testing products, and concerns related to variability in accuracy and precision may hamper the growth of the POC coagulation testing industry over the forecast period.

Global POC Coagulation Testing Market: Overview

Significant consumption of anticoagulant drugs

Anticoagulant drugs, also known as blood thinners, helps to reduce the chances of atrial fibrillation-related heart strokes by about 75%. The increasing consumption of these drugs is driving the need for coagulation testing procedures to monitor blood clotting. This demand will lead to the expansion of the global POC coagulation testing market at a CAGR of over 6% during the forecast period.

Automation in POC coagulation testing products

The development of automated POC coagulation testing products is increasing due to surging demand for faster turnaround times, automatic data uploading, and minimal human efforts. This has helped medical practitioners to perform rapid testing with minimal intervention. The automation in POC coagulation testing products is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global POC coagulation testing market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of several major players, the global POC coagulation testing market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC coagulation testing manufacturers, that include Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Medtronic Plc, and Siemens Healthineers AG.

Also, the POC coagulation testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY END-USER

Market segmentation by end-user

Comparison by end-user

Hospitals and clinics – Market size and forecast 2018-2023

Home care – Market size and forecast 2018-2023

Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 11: MARKET TRENDS

Automation in POC coagulation testing products

Application of POC coagulation testing in blood management

Growing demand from developing economies

PART 12: VENDOR LANDSCAPE

Overview

Landscape disruption

PART 13: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Abbott Laboratories

Danaher Corp.

F. Hoffmann-La Roche Ltd.

Medtronic Plc

Siemens Healthineers AG

PART 14: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Exhibit 01: Product overview

Exhibit 02: Global healthcare market

Exhibit 03: Segments of global healthcare market

Exhibit 04: Market characteristics

Exhibit 05: Market segments

Exhibit 06: Market definition – Inclusions and exclusions checklist

Exhibit 07: Market size 2018

Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 10: Five forces analysis 2018

Exhibit 11: Five forces analysis 2023

Exhibit 12: Bargaining power of buyers

Exhibit 13: Bargaining power of suppliers

Exhibit 14: Threat of new entrants

Exhibit 15: Threat of substitutes

Exhibit 16: Threat of rivalry

Exhibit 17: Market condition – Five forces 2018

Exhibit 18: End-user – Market share 2018-2023 (%)

Exhibit 19: Comparison by end-user

Exhibit 20: Hospitals and clinics – Market size and forecast 2018-2023 ($ millions)

Exhibit 21: Hospitals and clinics – Year-over-year growth 2019-2023 (%)

Exhibit 22: Home care – Market size and forecast 2018-2023 ($ millions)

Exhibit 23: Home care – Year-over-year growth 2019-2023 (%)

Exhibit 24: Market opportunity by end-user

Exhibit 25: Customer landscape

Exhibit 26: Market share by geography 2018-2023 (%)

Exhibit 27: Geographic comparison

Exhibit 28: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 29: North America – Year-over-year growth 2019-2023 (%)

Exhibit 30: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 32: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 33: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 34: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 35: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 36: Key leading countries

Exhibit 37: Market opportunity

Exhibit 38: Impact of drivers and challenges

Exhibit 39: Vendor landscape

Exhibit 40: Landscape disruption

Exhibit 41: Vendors covered

Exhibit 42: Vendor classification

Exhibit 43: Market positioning of vendors

Exhibit 44: Abbott Laboratories – Vendor overview

Exhibit 45: Abbott Laboratories – Business segments

Exhibit 46: Abbott Laboratories – Organizational developments

Exhibit 47: Abbott Laboratories – Geographic focus

Exhibit 48: Abbott Laboratories – Segment focus

Exhibit 49: Abbott Laboratories – Key offerings

Exhibit 50: Danaher Corp. – Vendor overview

Exhibit 51: Danaher Corp. – Product segments

Exhibit 52: Danaher Corp. – Organizational developments

Exhibit 53: Danaher Corp. – Geographic focus

Exhibit 54: Danaher Corp. – Segment focus

Exhibit 55: Danaher Corp. – Key offerings

Exhibit 56: F. Hoffmann-La Roche Ltd. – Vendor overview

Exhibit 57: F. Hoffmann-La Roche Ltd. – Product segments

Exhibit 58: F. Hoffmann-La Roche Ltd. – Organizational developments

Exhibit 59: F. Hoffmann-La Roche Ltd. – Geographic focus

Exhibit 60: F. Hoffmann-La Roche Ltd. – Segment focus

Exhibit 61: F. Hoffmann-La Roche Ltd. – Key offerings

Exhibit 62: Medtronic Plc – Vendor overview

Exhibit 63: Medtronic Plc – Business segments

Exhibit 64: Medtronic Plc – Organizational developments

Exhibit 65: Medtronic Plc – Geographic focus

Exhibit 66: Medtronic Plc – Segment focus

Exhibit 67: Medtronic Plc – Key offerings

Exhibit 68: Siemens Healthineers AG – Vendor overview

Exhibit 69: Siemens Healthineers AG – Business segments

Exhibit 70: Siemens Healthineers AG – Organizational developments

Exhibit 71: Siemens Healthineers AG – Geographic focus

Exhibit 72: Siemens Healthineers AG – Segment focus

Exhibit 73: Siemens Healthineers AG – Key offerings

Exhibit 74: Validation techniques employed for market sizing

Exhibit 75: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories, Danaher Corp., F. Hoffmann-La Roche Ltd., Medtronic Plc, and Siemens Healthineers AG.

★調査レポート[POC血液凝固検査の世界市場2019-2023] (コード:IRTNTR31829)販売に関する免責事項を必ずご確認ください。
★調査レポート[POC血液凝固検査の世界市場2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆